Outcome of children with IgA vasculitis with nephritis treated with steroids: a matched controlled study

Pediatr Nephrol. 2023 Oct;38(10):3317-3326. doi: 10.1007/s00467-023-05981-3. Epub 2023 May 8.

Abstract

Background: IgA vasculitis (IgAV) is the most common vasculitis in children. IgAV long-term prognosis depends on kidney involvement or IgA vasculitis with nephritis (IgAVN). To date, steroid treatment (oral steroids or methylprednisolone pulses) has not proven to be formally efficient. This study aimed to assess the role of steroids on IgAVN outcome.

Methods: All children with IgAVN diagnosed 2000-2019 in 14 French pediatric nephrology units with minimal follow-up of 6 months were retrospectively included. Outcomes of patients treated with steroids were compared with those of a control group of untreated patients matched for age, sex, proteinuria, eGFR, and histological features. The primary endpoint was IgAVN remission defined as urine protein-to-creatinine ratio < 20 mg/mmol without impaired eGFR one year after disease onset.

Results: A total of 359 patients with IgAVN were included with a median follow-up time of 249 days (range 43-809). One hundred eight (30%) patients received oral steroids alone, 207 (51%) patients received three methylprednisolone pulses followed by oral steroids, and 44 patients (12.5%) did not receive steroids. Thirty-two children treated with oral steroids alone were compared with 32 matched control patients who did not receive steroids. One year after disease onset, IgAVN remission proportion was not different between these two groups: 62% versus 68%, respectively. Ninety-three children treated with oral steroids alone were compared with 93 matched patients treated with three methylprednisolone pulses followed by oral corticosteroids. IgAVN remission proportion was not different between these two groups: 77% versus 73%, respectively.

Conclusion: The benefit of oral steroids alone and methylprednisolone pulses could not be established based on this observational study. Randomized controlled trials are thus required to determine the efficacy of steroids in IgAVN. A higher resolution version of the Graphical abstract is available as Supplementary information.

Keywords: Henoch–Schonlein purpura nephritis; IgA vasculitis with nephritis; Renal outcome; Steroids.

Publication types

  • Observational Study

MeSH terms

  • Child
  • Humans
  • IgA Vasculitis* / complications
  • IgA Vasculitis* / drug therapy
  • IgA Vasculitis* / pathology
  • Immunoglobulin A
  • Kidney / pathology
  • Methylprednisolone
  • Nephritis* / pathology
  • Retrospective Studies

Substances

  • Methylprednisolone
  • Immunoglobulin A